The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance.

Kowalska-Krochmal B, Dudek-Wicher R. · 2021

Read The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance. by Kowalska-Krochmal B, Dudek-Wicher R. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7913839.txt.

Introduction

Kowalska-Krochmal and Dudek-Wicher present a review of the minimum inhibitory concentration of antibiotics, known as the MIC. The MIC is the lowest drug level that stops a bacterial strain in the lab. It guides the choice of antibiotic for a patient. A wrong reading can lead to a failed therapy, so the method matters.

The authors discuss the two main ways to measure it: dilution and gradient methods. They explain the factors that can shift a result. Rules for reading and reporting the value are set out with care. The review then shows how the MIC joins with drug exposure measures in practice. Statistical tools can estimate the chance of hitting the right exposure in a given patient. The limits of the MIC close the account.

Catalog record

CREATORKowalska-Krochmal B, Dudek-Wicher R.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE73 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7913839

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance By Beata Kowalska-Krochmal, Ruth Dudek-Wicher, Lawrence S. Young, Po-Lin Chen Published in: Pathogens DOI: 10.3390/pathogens10020165 ABSTRACT Inefficiency of medical therapies used in order to cure patients with bacterial infections requires not only to actively look for new therapeutic strategies but also to carefully select antibiotics based on variety of parameters, including microbiological. Minimal inhibitory concentration (MIC) defines in vitro levels of susceptibility or resistance of specific bacterial strains to applied antibiotic. Reliable assessment of MIC has a significant impact on the choice of a therapeutic strategy, which affects efficiency of an infection therapy. In order to obtain credible MIC, many elements must be considered, such as proper method choice, adherence to labeling rules, and competent interpretation of the results. In this paper, two methods have been discussed: dilution and gradient used for MIC estimation. Factors which affect MIC results along with the interpretation guidelines have been described. Furthermore, opportunities to utilize MIC in clinical practice, with pharmacokinetic /pharmacodynamic parameters taken into consideration, have been investigated. Due to problems related to PK determination in individual patients, statistical estimation of the possibility of achievement of the PK/PD index, based on the Monte Carlo, was discussed. In order to provide comprehensive insights, the possible limitations of MIC, which scientists are aware of, have been outlined. 1. INTRODUCTION The increasing resistance of bacteria to antibiotics and more and more common failed infection treatments call for identification of the underlying causes of this problem and, further, for searching the ways to reduce it and to improve the effectiveness of infection therapies. One of the recognized reasons behind failed therapies is the drug selection pressure, especially when they are ill-chosen and administered in doses too small, which leads to the survival of a resistant bacterial population or induces antibiotic resistance mechanisms [1]. Therefore, it is very important to use antibiotics in true bacterial infections and in such doses so as to increase the likelihood of therapeutic effectiveness. During initial phases of infections, especially severe ones, empirical therapy is usually undertaken, where an antibiotic is selected depending on the location of the infection, the patient’s clinical condition, therapeutic history, concomitant diseases and organ dysfunctions. The antibiotic should be effective against probable pathogens, whose frequency of isolation and drug sensitivity should be known from epidemiological data obtained from a retrospective analysis of the results of multiple microbiological studies. Whenever possible, the administration of an antibiotic in empirical therapy should be preceded by sampling for microbiological tests, and the results of such tests should be the basis for verification of the validity of preliminary therapeutic decisions and for the application of a targeted therapy. Thus, in both empirical and targeted therapy, microbiological test results serve as a strong support for the choice of the optimal antibiotic. The identification of the pathogen, sometimes also including the determination of its quantity per 1 g or mL of the sample, combined with the results of analytical and clinical studies, is the basis for the definitive diagnosis of the infection. An antibiogram, on the other hand, suggests the choice of a drug expected to be clinically effective in bacterial infections. Commonly, antibiograms contain a qualitative assessment of a strain’s susceptibility or resistance to antibiotics as well as information about the detected resistance mechanisms. For many infections, such parameters are sufficient to stop the use of antibiotics already administered in case of the strain’s resistance and to replace it with a drug to which the strain is susceptible. However, in the case of seriously ill patients, who suffer from chronic infections, who have been treated with a broad range of antibiotics, and who have a history of failed therapies, much more precise guidance is needed to facilitate the selection of an optimal (i.e., effective) antibiotic. Among such microbiological parameters is the minimum inhibitory concentration (MIC) of the antimicrobial. This value has been known for a very long time. For many years it has been determined only occasionally but now it has been appearing increasingly frequently in the results of routine tests. However, the ability to use it for effective and optimal therapy is still limited and sometimes, despite much higher costs incurred than in qualitative methods, it is completely unused. 2. DEFINITION AND METHODS 2.1. What is MIC? MIC is the lowest concentration of an antibacterial agent expressed in mg/L (μg/mL) which, under strictly controlled in vitro conditions, completely prevents visible growth of the test strain of an organism [2]. 2.2. MIC Determination Methods The following methods are used:Dilution methodsin agarin a liquid medium○micromethod/ microdilution○macromethod/ macrodilutionGradient methodsstrips impregnated with a predefined concentration gradient of antibiotic 2.2.1. Dilution Methods EUCAST [3] mostly recommends broth microdilution, with the exception of fosfomycin and mecillinam for which it recommends agar dilution. The American CLSI [4], on the other hand, admits interchangeable use of broth and agar dilution for most bacteria and antibiotics. The exceptions are H. influenzae strains and antibiotics colistin and daptomycin for which MIC can be determined only by broth dilution and fosfomycin for which, like in EUCAST guidance documents, MIC can be measured using the agar dilution method. In addition, CLSI recommends HTM medium for H. influenzae instead of the MH–F broth medium recommended by EUCAST. To determine MIC values, all quantitative methods use Mueller–Hinton (MH) medium either in the form of agar (MHA) or broth (MHB), in some cases additionally supplemented with, for example, 5% lysed horse blood or other compounds depending on bacteria or antibiotic type (Table 1). Only for anaerobic bacteria Brucella agar with Hemin (5 µg/mL), Vitamin K (1 µg/mL) and 5% lysed horse blood is used [4,5]. To determine MIC by dilution methods, antibiotics are also needed in a substance that require preliminary dissolution to obtain a stock solution and then dilution to obtain an appropriate starting concentration. For most antibiotics, water is both a solvent and a diluter, including for most beta-lactams, fluoroquinolones and aminoglycosides. Some require alcohol as a solvent, especially macrolides, chloramphenicol and rifampicin, while others require a phosphate buffer or dimethyl sulfoxide DMSO (Table 2). Dissolved and diluted antibiotics are used to make working solutions in Mueller-Hinton broth or agar [6,7]. Working solutions should contain double dilutions of antibiotics, with the range of concentrations used for testing depending on the medication concerned and should take into account the MIC breakpoints for reference strains [6]. Subsequent double dilutions of the antibiotic should be performed using the schemes available in the documents [6] and proposed by EUCAST [8]. In the broth microdilution method, the prepared working solutions with double dilutions of antibiotics are distributed into appropriate wells of microtiter plates, and in this form they can be either used directly for MIC determinations or can be stored in plastic bags for up to three months at a temperature ≤ −60 °C [6]. Tigecycline is an exception for which MIC testing should take place within 12 h of the preparation of the MHB medium. This is due to the fact that over time, the medium accumulates oxygen, which in turn reduces the activity of tigecycline [3,4,6,9]. In the agar dilution method, each of the obtained antibiotic concentrations at a volume of 1 mL is added to 19 mL of

Read the complete text